Stock comparison
EXPONENT INC is 1.2x more valuable than Astrana Health, Inc. by market capitalization ($3.02 B vs $2.61 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
EXPO is larger
EXPONENT INC is 1.2x more valuable than Astrana Health, Inc. by market capitalization ($3.02 B vs $2.61 B).
Market value leader
EXPO
EXPONENT INC is 1.2x more valuable than Astrana Health, Inc. by market capitalization ($3.02 B vs $2.61 B).
Revenue leader
ASTH
ASTH: $3.18B vs EXPO: $582.01M.
Profit leader
EXPO
ASTH: $24.00M vs EXPO: $106.01M.
Margin leader
EXPO
ASTH: 0.8% vs EXPO: 18.2% net margin.
| Metric | ASTH | EXPO |
|---|---|---|
| Market cap | $2.61 B | $3.02 B |
| US-listed rank | #1946 | #1821 |
| Revenue (latest FY) | $3.18B | $582.01M |
| Net income (latest FY) | $24.00M | $106.01M |
| Net margin | 0.8% | 18.2% |
| P/E (trailing FY) | 108.7x | 28.5x |
| SEC filings | 1,003 | 2,029 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
EXPONENT INC is 1.2x more valuable than Astrana Health, Inc. by market capitalization ($3.02 B vs $2.61 B).
In their latest fiscal years, Astrana Health, Inc. reported $3.18B in revenue while EXPONENT INC reported $582.01M.
Full pages: Astrana Health, Inc. and EXPONENT INC, or browse the full rankings.